370 related articles for article (PubMed ID: 16404503)
1. Pharmacokinetic-pharmacodynamic modelling: history and perspectives.
Csajka C; Verotta D
J Pharmacokinet Pharmacodyn; 2006 Jun; 33(3):227-79. PubMed ID: 16404503
[TBL] [Abstract][Full Text] [Related]
2. Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.
Meibohm B; Derendorf H
Int J Clin Pharmacol Ther; 1997 Oct; 35(10):401-13. PubMed ID: 9352388
[TBL] [Abstract][Full Text] [Related]
3. PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: principles and applications in veterinary pharmacology.
Lees P; Giraudel J; Landoni MF; Toutain PL
J Vet Pharmacol Ther; 2004 Dec; 27(6):491-502. PubMed ID: 15601443
[TBL] [Abstract][Full Text] [Related]
4. Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.
Ayyar VS; Jusko WJ
Pharmacol Rev; 2020 Apr; 72(2):414-438. PubMed ID: 32123034
[TBL] [Abstract][Full Text] [Related]
5. Using pharmacokinetic/pharmacodynamic modelling in safety pharmacology to better define safety margins: a regional workshop of the Safety Pharmacology Society.
Cavero I
Expert Opin Drug Saf; 2007 Jul; 6(4):465-71. PubMed ID: 17688390
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers, validation and pharmacokinetic-pharmacodynamic modelling.
Colburn WA; Lee JW
Clin Pharmacokinet; 2003; 42(12):997-1022. PubMed ID: 12959633
[TBL] [Abstract][Full Text] [Related]
7. Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives.
Derendorf H; Meibohm B
Pharm Res; 1999 Feb; 16(2):176-85. PubMed ID: 10100300
[TBL] [Abstract][Full Text] [Related]
8. A pharmacokinetic-pharmacodynamic disease model to predict in vivo antiviral activity of maraviroc.
Rosario MC; Jacqmin P; Dorr P; van der Ryst E; Hitchcock C
Clin Pharmacol Ther; 2005 Nov; 78(5):508-19. PubMed ID: 16321617
[TBL] [Abstract][Full Text] [Related]
9. A regulatory perspective on pharmacokinetic/pharmacodynamic modelling.
Machado SG; Miller R; Hu C
Stat Methods Med Res; 1999 Sep; 8(3):217-45. PubMed ID: 10636336
[TBL] [Abstract][Full Text] [Related]
10. Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research.
Danhof M; de Lange EC; Della Pasqua OE; Ploeger BA; Voskuyl RA
Trends Pharmacol Sci; 2008 Apr; 29(4):186-91. PubMed ID: 18353445
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic-pharmacodynamic modeling: why?
Pérez-Urizar J; Granados-Soto V; Flores-Murrieta FJ; Castañeda-Hernández G
Arch Med Res; 2000; 31(6):539-45. PubMed ID: 11257318
[TBL] [Abstract][Full Text] [Related]
12. Methodological issues in pharmacokinetic-pharmacodynamic modelling.
Bellissant E; Sébille V; Paintaud G
Clin Pharmacokinet; 1998 Aug; 35(2):151-66. PubMed ID: 9739481
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic-pharmacodynamic (PK-PD) modelling in non-steady-state studies and arterio-venous drug concentration differences.
Gumbleton M; Oie S; Verotta D
Br J Clin Pharmacol; 1994 Nov; 38(5):389-400. PubMed ID: 7893578
[TBL] [Abstract][Full Text] [Related]
14. Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis.
Danhof M; de Jongh J; De Lange EC; Della Pasqua O; Ploeger BA; Voskuyl RA
Annu Rev Pharmacol Toxicol; 2007; 47():357-400. PubMed ID: 17067280
[TBL] [Abstract][Full Text] [Related]
15. PK/PD modelling and simulations: utility in drug development.
Rajman I
Drug Discov Today; 2008 Apr; 13(7-8):341-6. PubMed ID: 18405847
[TBL] [Abstract][Full Text] [Related]
16. Indirect pharmacodynamic response models do not require any parametric pharmacokinetic model to be fitted to effect-time data.
Piotrovsky VK
Methods Find Exp Clin Pharmacol; 1997 Dec; 19(10):723-9. PubMed ID: 9542723
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic data and models in clinical trials.
Steimer JL; Ebelin ME; Van Bree J
Eur J Drug Metab Pharmacokinet; 1993; 18(1):61-76. PubMed ID: 8335040
[TBL] [Abstract][Full Text] [Related]
18. Connection of pharmacokinetics and pharmacodynamics--how does it work?
Cawello W
Int J Clin Pharmacol Ther; 1997 Oct; 35(10):414-7. PubMed ID: 9352389
[TBL] [Abstract][Full Text] [Related]
19. Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine.
Toutain PL; Lees P
J Vet Pharmacol Ther; 2004 Dec; 27(6):467-77. PubMed ID: 15601441
[TBL] [Abstract][Full Text] [Related]
20. Expanding clinical applications of population pharmacodynamic modelling.
Minto C; Schnider T
Br J Clin Pharmacol; 1998 Oct; 46(4):321-33. PubMed ID: 9803979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
